Homeopathy as Therapy for Mycosis Fungoides: Case Reports of Three PatientsFunding None.
21 July 2018
06 March 2019
25 July 2019 (eFirst)
Background Mycosis fungoides (MF) is an uncommon, indolent, form of cutaneous T cell lymphoma, of which there are various types according to international classification. Various treatment modalities are available; however, these are fraught with potentially severe adverse effects.
Methods Three cases of immunohistochemically confirmed MF were treated with classical individualized homeopathy. Each case was followed up with photographic documentation and was reported according to the criteria set out in the HOM-CASE guidelines. Based on the WHO-EORTC (World Health Organization–European Organization for Research and Treatment of Cancer) criteria, the patients were classified as T1b, T1a/T1b and T2b respectively.
Results All cases remitted following homeopathic treatment and remained in remission. Side effects were not reported in these cases.
Conclusions MF may respond to individualized homeopathic medicine. Although the case number here is small, MF is not a common disorder, spontaneous remission is not usually expected, and the disease may progress to a more severe form. Hence, these findings could serve as a basis for further research into the role of individualized homeopathic medicine in the treatment of MF.
Keywordsmycosis fungoides - cutaneous T cell lymphoma - homeopathy - Sulphur - Lycopodium - treatment of cancer
This work was presented as an oral poster at the American Academy of Dermatology (AAD) meeting, 2017, held in Orlando (Nwabudike LC. Cutaneous T cell lymphoma (Mycosis fungoides) treated by homeopathy: A 3-case report. JAAD 2017;76:AB92. doi.org/10.1016/j.jaad.2017.04.371).
- 1 Willemze R, Jaffe ES, Burg G. , et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768-3785
- 2 Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions. J Am Acad Dermatol 2014; 70: 223.e1-223.e17
- 3 van Haselen RA. Homeopathic clinical case reports: development of a supplement (HOM-CASE) to the CARE clinical case reporting guideline. Complement Ther Med 2016; 25: 78-85
- 4 Olsen E, Vonderheid E, Pimpinelli N. , et al; ISCL/EORTC. Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110: 1713-1722
- 5 Aschebrook-Kilfoy B, Cocco P, La Vecchia C. , et al. Medical history, lifestyle, family history, and occupational risk factors for mycosis fungoides and Sézary syndrome: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr 2014; 2014: 98-105
- 6 Saunes M, Nilsen TI, Johannesen TB. Incidence of primary cutaneous T-cell lymphoma in Norway. Br J Dermatol 2009; 160: 376-379
- 7 Talpur R, Singh L, Daulat S. , et al. Long-term outcomes of 1,263 patients with mycosis fungoides and Sézary syndrome from 1982 to 2009. Clin Cancer Res 2012; 18: 5051-5060
- 8 Prince HM, Duvic M, Martin A, Sterry W, Assaf C, Straus DJ. Incidence of spontaneous remission in patients with CD25-positive mycosis fungoides/Sézary syndrome receiving placebo. J Am Acad Dermatol 2012; 67: 867-875
- 9 Weberschock T, Strametz R, Lorenz M. , et al. Interventions for mycosis fungoides. Cochrane Database Syst Rev 2012; 9: CD008946
- 10 Signore RJ. Treatment of lichen striatus with homeopathic calcium carbonate. J Amer Ost College Derm 2011; 21: 43
- 11 Witt CM, Lüdtke R, Willich SN. Homeopathic treatment of patients with psoriasis – a prospective observational study with 2 years follow-up. J Eur Acad Dermatol Venereol 2009; 23: 538-543
- 12 Nwabudike LC. Case reports of acne and homeopathy. Complement Med Res 2018; 25: 52-55
- 13 Nwabudike LC. Homeopathy in the treatment of dermatitis herpetiformis – a case presentation. Homoeopathic Links 2015; 28: 44-46
- 14 Trautinger F, Eder J, Asaf C. , et al. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017. Eur J Cancer 2017; 77: 57-74